These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

298 related articles for article (PubMed ID: 29134498)

  • 21. Use of Angiotensin II for Post Cardiopulmonary Bypass Vasoplegic Syndrome.
    Evans A; McCurdy MT; Weiner M; Zaku B; Chow JH
    Ann Thorac Surg; 2019 Jul; 108(1):e5-e7. PubMed ID: 30582924
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Methylene Blue: Magic Bullet for Vasoplegia?
    Hosseinian L; Weiner M; Levin MA; Fischer GW
    Anesth Analg; 2016 Jan; 122(1):194-201. PubMed ID: 26678471
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The Blue Coma: The Role of Methylene Blue in Unexplained Coma After Cardiac Surgery.
    Martino EA; Winterton D; Nardelli P; Pasin L; Calabrò MG; Bove T; Fanelli G; Zangrillo A; Landoni G
    J Cardiothorac Vasc Anesth; 2016 Apr; 30(2):423-7. PubMed ID: 26703972
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Guanylate cyclase inhibition by methylene blue as an option in the treatment of vasoplegia after a severe burn. A medical hypothesis.
    Farina Junior JA; Celotto AC; da Silva MF; Evora PR
    Med Sci Monit; 2012 May; 18(5):HY13-7. PubMed ID: 22534716
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A Novel Use of Methylene Blue in the Pediatric ICU.
    Rutledge C; Brown B; Benner K; Prabhakaran P; Hayes L
    Pediatrics; 2015 Oct; 136(4):e1030-4. PubMed ID: 26347436
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Vasoplegic Syndrome in Patients Undergoing Cardiac Surgery: A Literature Review.
    Nash CM
    AACN Adv Crit Care; 2021 Jun; 32(2):137-145. PubMed ID: 34161970
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Use of methylene blue to treat vasoplegia syndrome in cystic fibrosis patients undergoing lung transplantation: A case series.
    Washington GC; O'Donnell CT; Madhok J; Williams KM; Hill CC
    Ann Card Anaesth; 2023; 26(1):36-41. PubMed ID: 36722586
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hydroxocobalamin as Rescue Therapy in a Patient With Refractory Amlodipine-Induced Vasoplegia.
    Ayasa LA; Azar J; Odeh A; Ayyad M; Shbaita S; Zidan T; Awwad NA; Kawa NM; Awad W
    Cureus; 2023 May; 15(5):e38400. PubMed ID: 37265888
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Methylene blue is associated with poor outcomes in vasoplegic shock.
    Weiner MM; Lin HM; Danforth D; Rao S; Hosseinian L; Fischer GW
    J Cardiothorac Vasc Anesth; 2013 Dec; 27(6):1233-8. PubMed ID: 23972738
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The additional use of methylene blue has a decatecholaminisation effect on cardiac vasoplegic syndrome after cardiac surgery.
    Petermichl W; Gruber M; Schoeller I; Allouch K; Graf BM; Zausig YA
    J Cardiothorac Surg; 2021 Jul; 16(1):205. PubMed ID: 34321019
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Methylene Blue for Vasoplegia During Extracorporeal Membrane Oxygenation Support.
    Ortoleva J; Roberts RJ; Devine LT; French A; Kawabori M; Chen F; Shelton K; Dalia AA
    J Cardiothorac Vasc Anesth; 2021 Sep; 35(9):2694-2699. PubMed ID: 33455885
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Serotonin syndrome after cardiopulmonary bypass: a case demonstrating the interaction between methylene blue and selective serotonin reuptake inhibitors.
    Hanna ER; Clark JA
    A A Case Rep; 2014 May; 2(9):113-4. PubMed ID: 25611876
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Methylene blue for vasoplegic syndrome treatment in heart surgery: fifteen years of questions, answers, doubts and certainties.
    Evora PR; Ribeiro PJ; Vicente WV; Reis CL; Rodrigues AJ; Menardi AC; Alves Junior L; Evora PM; Bassetto S
    Rev Bras Cir Cardiovasc; 2009; 24(3):279-88. PubMed ID: 20011872
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Methylene Blue Monotherapy Compared With Combination Therapy With Hydroxocobalamin for the Treatment of Refractory Vasoplegic Syndrome: ARetrospective Cohort Study.
    Feih JT; Rinka JRG; Zundel MT
    J Cardiothorac Vasc Anesth; 2019 May; 33(5):1301-1307. PubMed ID: 30606508
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Why Methylene Blue Have to Be Always Present in the Stocking of Emergency Antidotes.
    Baldo CF; Silva LM; Arcencio L; Albuquerque AAS; Celotto AC; Basile-Filho A; Evora PRB
    Curr Drug Targets; 2018; 19(13):1550-1559. PubMed ID: 29611486
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Vasopressin and methylene blue: alternate therapies in vasodilatory shock.
    Lavigne D
    Semin Cardiothorac Vasc Anesth; 2010 Sep; 14(3):186-9. PubMed ID: 20705641
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Methylene blue for postcardiopulmonary bypass vasoplegic syndrome: A cohort study.
    Mazzeffi M; Hammer B; Chen E; Caridi-Scheible M; Ramsay J; Paciullo C
    Ann Card Anaesth; 2017; 20(2):178-181. PubMed ID: 28393777
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Vasoplegic syndrome--the role of methylene blue.
    Shanmugam G
    Eur J Cardiothorac Surg; 2005 Nov; 28(5):705-10. PubMed ID: 16143539
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Twenty years of vasoplegic syndrome treatment in heart surgery. Methylene blue revised.
    Evora PR; Alves Junior L; Ferreira CA; Menardi AC; Bassetto S; Rodrigues AJ; Scorzoni Filho A; Vicente WV
    Rev Bras Cir Cardiovasc; 2015; 30(1):84-92. PubMed ID: 25859872
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Methylene blue: potential use of an antique molecule in vasoplegic syndrome during cardiac surgery.
    Lenglet S; Mach F; Montecucco F
    Expert Rev Cardiovasc Ther; 2011 Dec; 9(12):1519-25. PubMed ID: 22103871
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.